アルファエミッターの市場規模、シェア、動向、予測：放射性核種タイプ別、医療用途別、エンドユーザー別、地域別、2025年～2033年

アルファエミッターの世界市場規模は、2024年に18億3,448万米ドルとなりました。今後、IMARC Groupは、市場は2033年までに120億4,020万米ドルに達し、2025年から2033年にかけて23.25%のCAGRを示すと予測しています。現在市場を独占しているのは北米で、2024年には43.7%以上の市場シェアを占めました。標的がん治療への注目の高まりや、核医学に基づく新製品の承認数の増加などの要因が、アルファエミッターのシェアを押し上げています。

アルファエミッターは、アルファ粒子を放出した後に崩壊する放射源から放出される物質です。適切な生体内分布とそれに伴う線量分布を実現し、許容できない急性・長期の副作用を引き起こすことなく効果的な治療を実現します。非常に高い殺細胞率を持つアルファ粒子は、医療処置に使用される場合、ベータ粒子よりも腫瘍細胞に対する破壊力が強いです。その結果、隣接する正常組織へのダメージが少ないです。治療過程で使用される放射性核種には、ラジウム、鉛、ビスマスなどがあります。アルファ粒子は飛程が短く、線エネルギー付与（LET）が高いため、医学研究、特にがんの治療法として非常に魅力的です。卵巣がん、膵臓がん、リンパ腫、メラノーマなど、アルファ線放出核種で治療できるがんの種類は数多くあります。

アルファエミッターの市場動向：

市場は、がん治療において行われている広範かつハイエンドの研究開発（R&D）活動によって大きく牽引されています。この背景には、標的アルファエミッターの殺細胞能力に関する意識の高まりがあります。これに伴い、大衆の間で様々な種類のがんの有病率が上昇しており、市場に弾みをつけています。また、多くの心臓疾患やがんを発症しやすい高齢者人口が増加していることも、市場に明るい展望をもたらしています。さらに、ヘルスケア施設における標的抗がん剤やアルファ線療法（TAT）の採用が増加していることも、市場にプラスの影響を与えています。さらに、継続的な技術の進歩や核医学ベースの新製品承認の増加も市場を後押ししています。その他、急速な都市化、ヘルスケアインフラの継続的な改善、医療費の増加、個人の可処分所得水準の上昇なども市場に寄与しています。

本レポートで扱う主な質問

• アルファエミッターの市場規模は？
• アルファエミッター市場の将来展望は？
• アルファエミッター市場を牽引する主な要因は何か？
• アルファエミッター市場のシェアが最も高い地域はどこか？
• 世界のアルファエミッター市場の主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界のアルファエミッター

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：放射性核種タイプ別

• アスタチン
• ラジウム
• アクチニウム
• 鉛
• ビスマス
• その他

第7章 市場内訳：医療用途別

• 前立腺がん
• 骨転移
• 卵巣がん
• 膵臓がん
• 内分泌腫瘍
• その他

第8章 市場内訳：エンドユーザー別

• 病院
• 医療研究機関
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Actinium Pharmaceuticals Inc.
  • Alpha Tau Medical Ltd.
  • Bayer AG
  • Fusion Pharmaceuticals
  • IBA RadioPharma Solutions
  • RadioMedix Inc.

List of Figures

• Figure 1: Global: Alpha Emitter Market: Major Drivers and Challenges
• Figure 2: Global: Alpha Emitter Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Alpha Emitter Market: Breakup by Type of Radionuclide (in %), 2024
• Figure 5: Global: Alpha Emitter Market: Breakup by Medical Application (in %), 2024
• Figure 6: Global: Alpha Emitter Market: Breakup by End User (in %), 2024
• Figure 7: Global: Alpha Emitter Market: Breakup by Region (in %), 2024
• Figure 8: Global: Alpha Emitter (Astatine) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Alpha Emitter (Astatine) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Alpha Emitter (Radium) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Alpha Emitter (Radium) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Alpha Emitter (Actinium) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Alpha Emitter (Actinium) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Alpha Emitter (Lead) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Alpha Emitter (Lead) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Alpha Emitter (Bismuth) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Alpha Emitter (Bismuth) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Alpha Emitter (Other Type of Radionuclides) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Alpha Emitter (Other Type of Radionuclides) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Alpha Emitter (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Alpha Emitter (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Alpha Emitter (Bone Metastasis) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Global: Alpha Emitter (Bone Metastasis) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Global: Alpha Emitter (Ovarian Cancer) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Global: Alpha Emitter (Ovarian Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: Global: Alpha Emitter (Pancreatic Cancer) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: Global: Alpha Emitter (Pancreatic Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Global: Alpha Emitter (Endocrine Tumors) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Global: Alpha Emitter (Endocrine Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: Global: Alpha Emitter (Other Medical Applications) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: Global: Alpha Emitter (Other Medical Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: Global: Alpha Emitter (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: Global: Alpha Emitter (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Global: Alpha Emitter (Medical Research Institutions) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Global: Alpha Emitter (Medical Research Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Global: Alpha Emitter (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Global: Alpha Emitter (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: North America: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: North America: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: United States: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: United States: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: Canada: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: Canada: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: Asia-Pacific: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: Asia-Pacific: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: China: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: China: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Japan: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Japan: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: India: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: India: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: South Korea: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: South Korea: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Australia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Australia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: Indonesia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Indonesia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Europe: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Europe: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Germany: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Germany: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: France: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: France: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: United Kingdom: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: United Kingdom: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Italy: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: Italy: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Spain: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Spain: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Russia: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Russia: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 76: Latin America: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 77: Latin America: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 78: Brazil: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 79: Brazil: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 80: Mexico: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 81: Mexico: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 82: Others: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 83: Others: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 84: Middle East and Africa: Alpha Emitter Market: Sales Value (in Million USD), 2019 & 2024
• Figure 85: Middle East and Africa: Alpha Emitter Market: Breakup by Country (in %), 2024
• Figure 86: Middle East and Africa: Alpha Emitter Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 87: Global: Alpha Emitter Industry: SWOT Analysis
• Figure 88: Global: Alpha Emitter Industry: Value Chain Analysis
• Figure 89: Global: Alpha Emitter Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Alpha Emitter Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Alpha Emitter Market Forecast: Breakup by Type of Radionuclide (in Million USD), 2025-2033
• Table 3: Global: Alpha Emitter Market Forecast: Breakup by Medical Application (in Million USD), 2025-2033
• Table 4: Global: Alpha Emitter Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 5: Global: Alpha Emitter Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Alpha Emitter Market: Competitive Structure
• Table 7: Global: Alpha Emitter Market: Key Players

The global alpha emitter market size was valued at USD 1,834.48 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 12,040.20 Million by 2033, exhibiting a CAGR of 23.25% from 2025-2033. North America currently dominates the market, holding a market share of over 43.7% in 2024. Factors such as the increasing focus on targeted cancer treatments, along with the rising number of new nuclear-medicine-based product approvals, are bolstering the alpha emitter market share.

Alpha emitters are substances emitted by radioactive sources that decay after releasing alpha particles. They achieve appropriate biodistribution and associated dose distribution to achieve effective therapy without causing unacceptable acute or long-term side effects. With their exceptionally high cell-killing rates, alpha particles are more destructive to tumor cells than beta particles when used in medical procedures. Consequently, they cause less damage to adjacent normal tissues. Radium, lead and bismuth are some of the radionuclides used in the treatment process. The short range and high linear energy transfer (LET) of alpha particles have made them remarkably appealing to medical research, particularly as a viable treatment method for cancer. There are numerous types of cancer that can be treated with alpha emitters, including ovarian cancer, pancreatic cancer, lymphoma, and melanoma.

Alpha Emitter Market Trends:

The market is majorly driven by extensive and high-end research and development (R&D) activities being conducted in cancer treatment. This can be attributed to the growing awareness regarding the cell-killing abilities of targeted alpha emitters. In line with this, the rising prevalence of various types of cancer among the masses is providing an impetus to the market. Also, the increasing geriatric population that is susceptible to develop numerous cardiac and cancer ailments is creating a positive outlook for the market. Moreover, the rising adoption of targeted anticancer or alpha therapy (TAT) in healthcare facilities is impacting the market positively. The market is further propelled by continual technological advancements and the growing number of new nuclear-medicine-based product approvals. Some of the other factors contributing to the market include rapid urbanization, continual improvements in healthcare infrastructure, rising medical expenditure and inflating disposable income levels of the individuals.

Key Market Segmentation:

Breakup by Type of Radionuclide:

• Astatine
• Radium
• Actinium
• Lead
• Bismuth
• Others

Breakup by Medical Application:

• Prostate Cancer
• Bone Metastasis
• Ovarian Cancer
• Pancreatic Cancer
• Endocrine Tumors
• Others

Breakup by End User:

• Hospitals
• Medical Research Institutions
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.

Key Questions Answered in This Report

• 1.How big is the alpha emitter market?
• 2.What is the future outlook of alpha emitter market?
• 3.What are the key factors driving the alpha emitter market?
• 4.Which region accounts for the largest alpha emitter market share?
• 5.Which are the leading companies in the global alpha emitter market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Alpha Emitter Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type of Radionuclide

• 6.1 Astatine
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Radium
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Actinium
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Lead
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Bismuth
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Medical Application

• 7.1 Prostate Cancer
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Bone Metastasis
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Ovarian Cancer
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Pancreatic Cancer
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Endocrine Tumors
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Medical Research Institutions
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Actinium Pharmaceuticals Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
  • 14.3.2 Alpha Tau Medical Ltd.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Bayer AG
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Fusion Pharmaceuticals
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
  • 14.3.5 IBA RadioPharma Solutions
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 RadioMedix Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio